Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
By: Blaž Lebar, Mitja Zidar, Janez Mravljak, Roman Šink, Aleš Žula and Stane Pajk
Authors
Mitja Zidar
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ljubljana, Slovenia
Language: English
Page range: 479 - 493
Accepted on: May 2, 2024
Published on: Sep 14, 2024
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Blaž Lebar, Mitja Zidar, Janez Mravljak, Roman Šink, Aleš Žula, Stane Pajk, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.